Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Epidemiology of pulmonary arterial hypertension.

Literature DB >> 17338925

Epidemiology of pulmonary arterial hypertension.

Abstract

Progress in understanding the basic biology and the development of new therapies for pulmonary arterial hypertension have led to improvements in survival. This article reviews clinically important changes in the classification of the pulmonary hypertensive diseases, as well as the epidemiology of various forms of pulmonary hypertension. The risk factors for the development of pulmonary arterial hypertension, prognostic markers, and the effects of current therapies on survival are discussed.

Entities: Disease

Mesh：

Substances：
Appetite Depressants

Year: 2007 PMID： 17338925 DOI： 10.1016/j.ccm.2006.11.012

Source DB: PubMed Journal: Clin Chest Med ISSN： 0272-5231 Impact factor: 2.878

Keyword Cloud
Cited

12 in total

1. Right and left ventricular myocardial perfusion reserves correlate with right ventricular function and pulmonary hemodynamics in patients with pulmonary arterial hypertension.

Authors: Jens Vogel-Claussen; Jan Skrok; Monda L Shehata; Sukhminder Singh; Christopher T Sibley; Danielle M Boyce; Noah Lechtzin; Reda E Girgis; Steven C Mathai; Thomas A Goldstein; Jie Zheng; João A C Lima; David A Bluemke; Paul M Hassoun
Journal: Radiology Date: 2010-10-22 Impact factor: 11.105

2. Comparison of body habitus in patients with pulmonary arterial hypertension enrolled in the Registry to Evaluate Early and Long-term PAH Disease Management with normative values from the National Health and Nutrition Examination Survey.

Authors: Charles D Burger; Aimee J Foreman; Dave P Miller; Robert E Safford; Michael D McGoon; David B Badesch
Journal: Mayo Clin Proc Date: 2011-02 Impact factor: 7.616

Review 3. How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.

Authors: Leonardo M Fabbri; Cynthia Boyd; Piera Boschetto; Klaus F Rabe; A Sonia Buist; Barbara Yawn; Bruce Leff; David M Kent; Holger J Schünemann
Journal: Proc Am Thorac Soc Date: 2012-12

4. Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension.

Authors: Nicole B Gabler; Benjamin French; Brian L Strom; Ziyue Liu; Harold I Palevsky; Darren B Taichman; Steven M Kawut; Scott D Halpern
Journal: Chest Date: 2011-09-22 Impact factor: 9.410

5. Increased right ventricular Septomarginal trabeculation mass is a novel marker for pulmonary hypertension: comparison with ventricular mass index and right ventricular mass.

Authors: Jens Vogel-Claussen; Monda L Shehata; Dirk Lossnitzer; Jan Skrok; Sukhminder Singh; Danielle Boyce; Noah Lechtzin; Reda E Girgis; Stephen C Mathai; Joao A Lima; David A Bluemke; Paul M Hassoun
Journal: Invest Radiol Date: 2011-09 Impact factor: 6.016

6. Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension.

Authors: Ryan J Tedford; James O Mudd; Reda E Girgis; Stephen C Mathai; Ari L Zaiman; Traci Housten-Harris; Danielle Boyce; Benjamin W Kelemen; Anita C Bacher; Ami A Shah; Laura K Hummers; Fredrick M Wigley; Stuart D Russell; Rajeev Saggar; Rajan Saggar; W Lowell Maughan; Paul M Hassoun; David A Kass
Journal: Circ Heart Fail Date: 2013-09-01 Impact factor: 8.790

Epidemiology of pulmonary arterial hypertension.

1. Right and left ventricular myocardial perfusion reserves correlate with right ventricular function and pulmonary hemodynamics in patients with pulmonary arterial hypertension.

2. Comparison of body habitus in patients with pulmonary arterial hypertension enrolled in the Registry to Evaluate Early and Long-term PAH Disease Management with normative values from the National Health and Nutrition Examination Survey.

Review 3. How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.

4. Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension.

5. Increased right ventricular Septomarginal trabeculation mass is a novel marker for pulmonary hypertension: comparison with ventricular mass index and right ventricular mass.

6. Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension.

7. Validation of 6-minute walk distance as a surrogate end point in pulmonary arterial hypertension trials.

8. Primary pulmonary arterial hypertension and autoimmune polyendocrine syndrome in a pediatric patient.

9. Pulmonary hypertension: diagnosis and management.

10. The Relationship Between HIV Infection and Cardiovascular Disease.